Pro12Ala polymorphism of peroxisome proliferator activated receptor gamma 2 may be associated with adverse neurodevelopment in European preterm babies
Abstract Introduction Prematurity is the leading cause of death and disability in children under 5 years of age. Understanding the molecular mechanisms of the biological processes involved in preterm brain injury may help develop novel neuroprotective treatment strategies. A growing body of evidence...
Main Authors: | Suresh Victor, Andrew Chew, Shona Falconer |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-08-01
|
Series: | Brain and Behavior |
Subjects: | |
Online Access: | https://doi.org/10.1002/brb3.2256 |
Similar Items
-
Genotyping of peroxisome proliferator-activated receptor gamma (PPAR-γ) polymorphism (Pro12Ala) in Iranian population
by: Fatemeh Namvaran, et al.
Published: (2011-01-01) -
Peroxisome proliferator activated receptor gamma polymorphism Pro12Ala in polycystic ovary syndrome (PCOS) of South Indian Population
by: Raichel Jacob, et al.
Published: (2016-05-01) -
Evaluation of single nucleotide polymorphisms of Pro12Ala in peroxisome proliferator-activated receptor-γ and Gly308Ala in tumor necrosis factor-α genes in obese Asian Indians: a population-based study
by: Gupta R
Published: (2010-10-01) -
Peroxisome proliferator-activated receptor gamma agonist as a novel treatment for interstitial cystitis: A rat model
by: Amandeep Mahal, et al.
Published: (2018-07-01) -
The role of peroxisome proliferator-activated receptor gamma in prostate cancer
by: Catherine Elix, et al.
Published: (2018-01-01)